Access to medicines versus access to treatment: the case of type 1 diabetes

Bull World Health Organ. 2008 Aug;86(8):648-9. doi: 10.2471/blt.07.048710.
No abstract available

Publication types

  • Comment
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Africa
  • Chronic Disease / drug therapy*
  • Developing Countries* / economics
  • Diabetes Mellitus, Type 1 / drug therapy*
  • Drug Costs
  • Drug Industry
  • Drugs, Essential / economics*
  • Drugs, Essential / supply & distribution
  • Drugs, Generic / economics
  • Drugs, Generic / supply & distribution
  • Health Services Accessibility / economics*
  • Health Services Accessibility / ethics
  • Health Services Accessibility / organization & administration
  • Humans
  • Hypoglycemic Agents / economics*
  • Hypoglycemic Agents / supply & distribution
  • Hypoglycemic Agents / therapeutic use
  • Insulin / economics*
  • Insulin / supply & distribution
  • Insulin / therapeutic use

Substances

  • Drugs, Essential
  • Drugs, Generic
  • Hypoglycemic Agents
  • Insulin